HBO Max’s medical drama “The Pitt” has solidified its position as a major contender in this year’s Emmy Awards, earning 25 nominations, including 13 acting nods. The show, set in a Pittsburgh hospital emergency room, received recognition in categories spanning lead, supporting, and guest performances, as well as writing and directing.
Noah Wyle, who serves as both executive producer and lead actor, received a nomination for Outstanding Lead Actor for his role as Dr. Michael “Robby” Robinavitch, the emotionally complex head of the ER. Katherine LaNasa secured her second nomination in the Outstanding Supporting Actress category for her portrayal of charge nurse Dana Evans. Alongside LaNasa, Sepideh Moafi, who joined the cast in the second season as Dr. Baran Al-Hashimi, was also recognized. Two other supporting actress nominees include first-time contenders Taylor Dearden, who plays Dr. Melissa “Mel” King, and Fiona Dourif as Dr. Cassie McKay.
The supporting actor category saw nominations for Patrick Ball as Dr. Frank Langdon, Gerran Howell as Dr. Dennis Whittaker, and Shawn Hatosy, who was also a guest actor nominee, for his role as Dr. Jack Abbot. The series garnered additional attention in guest actor and actress categories for Tina Ivlev (patient Ilana Miller), Tal Anderson (Mel’s sister Becca King), Brittany Allen (cancer patient Roxie Hamler), Jeff Kober (Robby’s friend Duke Ekins), and Ernest Harden Jr. (Louie Cloverfield, a recurring patient battling alcoholism).
The total of 13 acting nominations stands just one shy of HBO’s “Succession,” which holds the record in this area. Beyond acting, “The Pitt” earned two nominations for writing and one for directing.
Since its debut in January 2025, the series has been widely praised for its authentic depiction of a hospital emergency department, combining intense medical cases with character-driven storytelling. The first season was notably successful at the Emmys, receiving 13 nominations and winning five, including Outstanding Drama Series and awards for Wyle, LaNasa, Hatosy as guest actor, and casting.
R. Scott Gemmill, the show’s creator and showrunner, addressed the challenges of following up on its initial success in an interview, noting the added pressure but emphasizing a commitment to strong storytelling. “We try not to focus on that, and just really focus on the characters and the stories and do what we did the first season — tell really authentic, strong stories,” he said.
The second season, which aired recently to positive critical reception, is centered on a single shift over the Fourth of July. It explores the strain of managing complex patients while navigating leadership changes as Dr. Robby prepares for a planned three-month sabbatical, and Dr. Baran Al-Hashimi steps in as his successor.
Production on the third season is currently underway, with a premiere set for next year.